Health Buzz: Study Says Vioxx Risks Were Apparent Early and Other Health News
Breast cancer risk not so easy to gauge; Thanksgiving meal tips for people with diabetes or allergies.
December 17, 2009
Federal judge orders 3rd trial in case against Vioxx maker Merck
Associated Press - May 30, 2007 7:54 PM ET NEW ORLEANS (AP) - A federal judge in New Orleans has ordered a third trial in a lawsuit by a woman who blamed Merck and Company's painkiller Vioxx
New England Journal: Merck Concealed Vioxx Study Info
The New England Journal of Medicine on Thursday said Merck withheld information about the cardiac side effects of Vioxx when it gave the journal data from a key trial on the drug's safety in 2000.
Study: Celebrex, Vioxx marketing led to overuse (Newsday)
A majority of the patients who were persuaded to use prescription arthritis drugs Celebrex and Vioxx would have done just as well on older, cheaper medications and would have avoided the potential heart and stroke risks now linked to those blockbuster drugs, according to a study of how they were marketed.
